![Robert Seguso](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Robert Seguso
Direktor/Vorstandsmitglied bei SignPath Pharma, Inc.
Profil
Robert Seguso is currently working as a Director at SignPath Pharma, Inc. He previously worked as the President, Chief Executive & Financial Officer at Seguso Holdings, Inc. from 2004 to 2010.
Aktive Positionen von Robert Seguso
Unternehmen | Position | Beginn |
---|---|---|
SignPath Pharma, Inc.
![]() SignPath Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services SignPath Pharma, Inc. operates as a development stage biotechnology company. It engages in the research and development of curcumin formulations for the treatment of cancer, neurologic disorders and mitigates drug-induced cardiac arrhythmia. The company was founded by Bruce Meyers in May 15, 2006 and is headquartered in Sandy, UT. | Direktor/Vorstandsmitglied | 01.03.2017 |
Ehemalige bekannte Positionen von Robert Seguso
Unternehmen | Position | Ende |
---|---|---|
Seguso Holdings, Inc.
![]() Seguso Holdings, Inc. Financial ConglomeratesFinance Seguso Holdings, Inc. operates as a blank check company. It serves as a vehicle to effect a merger, exchange of capital stock, and asset acquisition. The company was founded by Robert Seguso on October 21, 2004 and is headquartered in Bradenton, FL. | Finanzdirektor/CFO | 15.06.2010 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Seguso Holdings, Inc.
![]() Seguso Holdings, Inc. Financial ConglomeratesFinance Seguso Holdings, Inc. operates as a blank check company. It serves as a vehicle to effect a merger, exchange of capital stock, and asset acquisition. The company was founded by Robert Seguso on October 21, 2004 and is headquartered in Bradenton, FL. | Finance |
SignPath Pharma, Inc.
![]() SignPath Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services SignPath Pharma, Inc. operates as a development stage biotechnology company. It engages in the research and development of curcumin formulations for the treatment of cancer, neurologic disorders and mitigates drug-induced cardiac arrhythmia. The company was founded by Bruce Meyers in May 15, 2006 and is headquartered in Sandy, UT. | Commercial Services |